Shockwave Medical, Inc. (SWAV)

May 31, 2024 - SWAV was delisted (reason: acquired by JNJ)

334.75

0.00 (0.00%)

Inactive · Last trade price on May 30, 2024

ShockWave Medical Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	787.97	730.23	489.73	237.15	67.79	42.93
Revenue Growth	41.42%	49.11%	106.51%	249.83%	57.92%	250.05%
Gross Profit	685.44	634.84	424.74	195.71	46.8	25.77
Operating Income	168.59	165.99	124.13	-0.87	-65.66	-51.84
Net Income	163.5	147.28	216	-9.14	-65.7	-51.11
Earnings Per Share	4.26	3.85	5.70	-0.26	-1.99	-2.14
EPS Growth	-32.67%	-32.46%	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Investments	1,029	990.55	304.49	200.98	202.35	195.35
Total Debt	776.8	770.61	60.4	47.19	24.98	22.72
Net Cash (Debt)	252.43	219.95	244.09	153.79	177.37	172.63
Net Cash Growth	-8.96%	-9.89%	58.71%	-13.30%	2.75%	601.95%
Net Cash Per Share	6.59	5.76	6.44	4.38	5.36	7.22

Cash Flow & CapEx

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Operating Cash Flow	197.93	196.05	117.73	15.04	-71.18	-48.11
Capital Expenditures	-31.8	-30.6	-25.13	-12.44	-11.52	-3.82
Free Cash Flow	166.14	165.46	92.61	2.6	-82.7	-51.92
Free Cash Flow Growth	37.61%	78.67%	3465.88%	-	-	-

Margins

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Gross Margin	86.99%	86.94%	86.73%	82.53%	69.03%	60.03%
Operating Margin	21.39%	22.73%	25.35%	-0.37%	-96.86%	-120.76%
Pretax Margin	23.29%	23.87%	24.67%	-3.73%	-96.80%	-118.92%
Profit Margin	20.75%	20.17%	44.10%	-3.85%	-96.92%	-119.06%
FCF Margin	21.08%	22.66%	18.91%	1.09%	-122.00%	-120.96%

Valuation

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug '26 Aug 5, 2026	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
PE Ratio	-	47.74	34.40	-	-	-
P/FCF Ratio	-	42.49	80.25	2424.28	-	-
PS Ratio	-	9.63	15.17	26.55	52.42	31.45